Cargando…
High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study
BACKGROUND: Coronavirus disease 2019(COVID-19) has spread worldwide. The present study aimed to characterize the clinical features and outcomes of imported COVID-19 patients with high body mass index (BMI) and the independent association of BMI with disease severity. METHODS: In this retrospective c...
Autores principales: | Cai, Huan, Yang, Lisha, Lu, Yingfeng, Zhang, Shanyan, Ye, Chanyuan, Zhang, Xiaoli, Yu, Guodong, Gu, Jueqing, Lian, Jiangshan, Hao, Shaorui, Hu, Jianhua, Zhang, Yimin, Jin, Ciliang, Sheng, Jifang, Yang, Yida, Jia, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863059/ https://www.ncbi.nlm.nih.gov/pubmed/33546633 http://dx.doi.org/10.1186/s12879-021-05818-0 |
Ejemplares similares
-
Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings
por: Zhang, Xiaoli, et al.
Publicado: (2020) -
High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study
por: Lian, Jiangshan, et al.
Publicado: (2020) -
COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome
por: Hu, Jianhua, et al.
Publicado: (2020) -
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID‐19) from Zhejiang province in China
por: Lian, Jiangshan, et al.
Publicado: (2020) -
Immunomodulatory and Antiviral Therapy Improved Functional Cure Rate in CHB Patients with High HBsAg Level Experienced NA
por: Jia, Hongyu, et al.
Publicado: (2023)